De vertaling van deze pagina is experimenteel en in ontwikkeling. Uw is welkom!
GeneReach Biotechnology Beheer
Beheer criteriumcontroles 1/4
Momenteel beschikken wij niet over voldoende informatie over de CEO.
Belangrijke informatie
Grace Chang
Algemeen directeur
n/a
Totale compensatie
| Percentage CEO-salaris | n/a |
| Dienstverband CEO | no data |
| Eigendom CEO | n/a |
| Management gemiddelde ambtstermijn | 6.8yrs |
| Gemiddelde ambtstermijn bestuur | geen gegevens |
Recente managementupdates
Recent updates
Does GeneReach Biotechnology (GTSM:4171) Have A Healthy Balance Sheet?
Apr 18
Will Weakness in GeneReach Biotechnology Corp.'s (GTSM:4171) Stock Prove Temporary Given Strong Fundamentals?
Feb 28We Like GeneReach Biotechnology's (GTSM:4171) Returns And Here's How They're Trending
Jan 31The GeneReach Biotechnology (GTSM:4171) Share Price Is Up 596% And Shareholders Are Delighted
Dec 27
GeneReach Biotechnology Corp.'s (GTSM:4171) Fundamentals Look Pretty Strong: Could The Market Be Wrong About The Stock?
Nov 28CEO
Grace Chang
no data
Tenure
Ms. Grace Chang, Ph D., serves as Chief Executive Officer at GeneReach Biotechnology Corp. Ms. Chang holds Ph.D. in Nutritional Science and Toxicology from UC Berkeley in the year 1993 to 1998 and B.S. in...
Leiderschapsteam
| Naam | Positie | Tenure | Compensatie | Eigendom |
|---|---|---|---|---|
| Chief Executive Officer | no data | geen gegevens | geen gegevens | |
| Chief Operation Officer | 4.8yrs | geen gegevens | geen gegevens | |
| Chief Technology Officer | 6.8yrs | geen gegevens | geen gegevens | |
| Vice President of Compliance Operation | no data | geen gegevens | geen gegevens | |
| Chief Commercial Officer | 6.8yrs | geen gegevens | geen gegevens |
6.8yrs
Gemiddelde duur
Ervaren management: Het managementteam van 4171 is doorgewinterd en ervaren (gemiddelde ambtstermijn van 6.8 jaar).